According to a leader from the pharma firm, considering a patient’s needs and seeing them as a whole person is vital to successful studies and drug design.
This year, global pharmaceutical company launched its Patient-Informed Development and Health Value translation team, an effort to ensure patient centricity is a top priority at every level of the drug development process. Victoria DiBiaso, global head of the team, discussed the patient-centric culture at the company and the importance of integrating the patient perspective throughout the pipeline.
OSP: What does it mean for pharma companies and their research partners to be truly ‘patient centric’ in their studies?
MedCity News
Rebuild clinical trials in the image of patient need. Join Sanofi, Janssen, FDA, Pfizer and more
Clinical 2021 is US and EU pharma’s leading event for clinical innovators - join 500+ executive attendees from across the globe to meet and learn virtually.
Shares0
Clinical is under the microscope. As the world focuses its lens on pharma, the opportunity and the pressure are there to establish a new era of agile, patient-centric clinical trials. Long standing barriers to innovation are being swiftly dismantled, digital transformation is accelerating, and a culture of novel collaboration, agility and patient centricity is growing.
Reuters Events’ Clinical 2021 (April 7-9) is the new home of clinical collaboration, innovation and discovery. Join hundreds of pharma clinical innovators plus leaders from across the business, such as real-world evidence, medical, and patient centricity, alongside key regulatory bodies, providers, and patient representatives to form new